Effects of Recombinant Human Erythropoietin on Resistance Artery Endothelial Function in Stage 4 Chronic Kidney Disease

BACKGROUND: Recent studies have raised concern about the safety of erythropoiesis‐stimulating agents because of evidence of increased risk of hypertension and cardiovascular morbidity and mortality in chronic kidney disease (CKD) patients. In the present study, we investigated the effects of recombi...

Descripción completa

Detalles Bibliográficos
Autores principales: Briet, Marie, Barhoumi, Tlili, Mian, Muhammad Oneeb Rehman, Sierra, Cristina, Boutouyrie, Pierre, Davidman, Michael, Bercovitch, David, Nessim, Sharon J., Frisch, Gershon, Paradis, Pierre, Lipman, Mark L., Schiffrin, Ernesto L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647261/
https://www.ncbi.nlm.nih.gov/pubmed/23584809
http://dx.doi.org/10.1161/JAHA.113.000128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647261/
https://www.ncbi.nlm.nih.gov/pubmed/23584809
http://dx.doi.org/10.1161/JAHA.113.000128

Ejemplares similares